RusNano still has $6B to invest in nanobio; Biotie in talks with alternative partners for Alzheimer's drug;

@FierceBiotech: Google software could aid drug design. Article | Follow @FierceBiotech

@JohnCFierce: Dealmaking rule no. 1: always claim to have multiple bidders interested in a product. Like Biotie on Alzheimer's program. More | Follow @JohnCFierce

@RyanMFierce: Here's my take and some inside dope one of biopharma's hottest job markets. Piece | Follow @RyanMFierce

@MarkHFierce: I'll start with something slightly off topic because it is so unbelievably cool. Scientists sprout an ancient plant. Story | Follow @MarkHFierce

> Institutional Investor takes a look at RusNano, which has another $6 billion to invest in nanotech and nanobio companies. Story

> Finland's Biotie claims it is unconcerned whether Roche ($RHHBY) will exercise an option on its Alzheimer's program. The CEO says it has other interested partners waiting in the wings in case Roche passes on the treatment. Report

> Israel's So-Gel Technologies says it has inked a $27 million deal with a U.S. pharma company for a new dermatological drug. Report

> Lumena Pharmaceuticals has raised $2 million for its work on diabetes treatments. Story

Pharma News

@FiercePharma: New M&A regs won't put a damper on Indian pharma deals, survey finds. More | Follow @FiercePharma

> Quebec plant fixes force Sandoz to slash output. Story

> FDA brings Sun's Doxil copy online to fix shortage. Piece

> With Hisun JV inked, Pfizer eyes other Chinese tie-ups. Article

> Pfizer reportedly weighing animal health IPO. More

IT News

> Oracle aids Moffitt Cancer Center’s IT system for speeding patient recruitment. Article

> Global Alzheimer's researchers seek cloud-based infrastructure to share data. News

> Eisai's H3 Biomedicine taps cancer genomics software for drug discovery effort. More

> Big Pharma activity eyed in mobile trends. Item

Manufacturing News

> Hospira on track with expansions in India. Story

> Leader of Pakistan drugmakers resigns in frustration. News

> Avastin alert likely to revive discussion of pharma-financed tracking system. Article

> Teva halts production of drug in U.K. Item

Research News

> Engineered measles virus prolongs lifespan of brain cancer-stricken mice. More

> Amniotic stem cells boost kidney disease survival time. Story

> Tobacco-chewing may damage crucial gene. Item

> Humans to test T-cell treatment that subdued canine lymphoma. Article

> Flu, over time, could increase Alzheimer's vulnerability. Piece

> Can omega-3 fatty acids beat back cancer? Maybe not. More

And Finally... Investigators say hepatitis has now become more deadly than HIV in the U.S. Report